Melatonin reverses EGFR-TKI therapeutic resistance by modulating crosstalk between circadian-related gene signature and immune infiltration patterns in patients with COVID-19 and lung adenocarcinoma sciencedirect.com/science/articl…

When a person gets cancer, A FAMILY gets cancer! Time and time again, my family has experienced it, and we all say (as we raise our middle finger 🖕 🫢), #MakeCancerLessShitty! Make Cancer Less Shitty AdvocateCollaborative (ACE) Stacey Tinianov (she/her) MPH, BCPA

LncRNA MALAT-1 modulates EGFR-TKI resistance in lung adenocarcinoma cells by downregulating miR-125 link.springer.com/article/10.100…

How can we improve survival for people w EGFR #lungcancer w P53 mutations? Dr @CrispinHiley UCLH says “We can treat these patients more selectively…intensive follow up, early RT or ablation or use of drug combinations.” ucl.ac.uk/news/2024/jun/… The Crick #LCSM Eva Grönroos

🫁 MARIPOSA 🫁 🌟 Published Annals of Oncology 📌 biomarkers of high-risk disease #ASCO24, #8504 Enriqueta Felip ESMO - Eur. Oncology EGFR Resisters EGFRm NSCLC EGFR Positive Lung Cancer UK EGFR Resisters #egfr #LCSM 📌 The paper is here. (Open access） x.gd/ecTqa

Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC cell.com/cell-reports/f…

Laura Greco of “Die, Cancer, Die!” Fame will be Remembered for her Passionate Patient Advocacy ilcn.org/laura-greco-of… 🤍🤍🤍

Hot off the press! We are proud to share our Roadmap on Cancer Persister Cells just published on Nature Reviews Cancer, a joint effort with outstanding scientists in the field to outline challenges and (exciting) future perspectives Persisters: rdcu.be/dSJp4

A real world analysis of secondary BRAF variations after targeted therapy resistance in driver gene positive NSCLC nature.com/articles/s4159…

🚨Why should we study circulating tumor DNA (ctDNA)?🧬 Discover how my research on #ctDNA aims to uncover cancer drivers, enable earlier diagnosis, and pave the way for new treatments 💉💊 ⁦Moffitt Cancer Center⁩ ⁦Moffitt Research⁩ #Womeninresearch #NSCLC #MoffittAmbassadors

🎯 Calling all #LungCancer researchers! Submit your abstract for #EGFRSummit DEADLINE Sept 30➡ce.ceconcepts.com/EGFR24 Jill Feldman Zosia Piotrowska Stephen V Liu, MD Helena Yu Mary Jo Fidler Christine Lovly, MD, PhD @egfrresisters @CEC_onc #LCSM #EGFR

🚨“Can’t-miss” lung cancer abstracts to be presented at #ESMO24! OncoAlert Hidehito HORINOUCHI Biagio Ricciuti, MD PhD Eric K. Singhi, MD Gil Morgan, MD

Join us at #ESMO24 on Sunday, Sep 15, for our symposium to discuss the latest evidences on NSCLC harbouring EGFR mutations The session will be great - with Drs. Noemi Reguart Enriqueta Felip Sanjay Popat Alex Spira, M.D. and me! Hope to see you there! #LCSM

LCRF is pleased to announce its collaboration with Bayer Pharmaceuticals to fund two research grants focused on innovative strategies to advance understanding and management of #LungCancer with HER2 mutations and/or other HER2 alterations. Find out more at LCRF.org/her2research

💎COMING SOON💎 Ep 1 of YLCI Podcast: Patient Education Series – Misconceptions of Clinical Trials, in collaboration w/ EGFR Resisters & sponsored by Black Diamond Therapeutics Dr Hajdenberg joins Stage 4 EGFR patients Leah & Karly to explore the importance of clinical trials

Our September newsletter is out now!Read about latest research, clinical trial updates, educational events, and meet Karen Bonte, who shares her lung cancer journey in our new Members Spotlight. mailchi.mp/d9891e8b1254/s…

Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling aacrjournals.org/clincancerres/…

This is Anthony’s reason for joining the 23andMe lung cancer and genetics study. What is YOUR reason? Join the study here ➡️ 23andme.com/lung-cancer/?u…

Dad 🥹

Interesting EGFR neoantigen therapy for EGFR+ NSCLC to overcome resistance presented at WCLC. New avenue which should be further explored! # MedIQWCLC24 #WCLC24